Back to primary school
- 1 July 1995
- journal article
- Published by Springer Nature in Nature
- Vol. 376 (6536) , 115
- https://doi.org/10.1038/376115a0
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer.The Journal of Experimental Medicine, 1995
- Enhancement of Infectivity of a Non‐Syncytium Inducing HIV‐1 by sCD4 and by Human Antibodies that Neutralize Syncytium Inducing HIV‐1Scandinavian Journal of Immunology, 1995
- HIV-1MN recombinant gp120 vaccine serum, which fails to neutralize primary isolates of HIV-1, does not antagonize neutralization by antibodies from infected individualsAIDS, 1994
- Dilemma of Neutralization Resistance of HIV-1 Field Isolates and Vaccine DevelopmentAIDS Research and Human Retroviruses, 1994
- Monoclonal Antibodies to the Extracellular Domain of HIV-1IIIB gp160 that Neutralize Infectivity, Block Binding to CD4, and React with Diverse IsolatesAIDS Research and Human Retroviruses, 1992
- Receptor-Mediated Activation of Immunodeficiency Viruses in Viral FusionScience, 1991
- High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.Proceedings of the National Academy of Sciences, 1990
- Enhancement of SIV Infection with Soluble Receptor MoleculesScience, 1990